January 16, 2009 - St. Jude Medical Inc. today said results from the landmark FAME (Fractional flow reserve (FFR) vs. Angiography in Multivessel Evaluation) study, which demonstrate a statistically significant 30 percent difference in major adverse cardiac events (MACE) such as death, myocardial infarction and repeat revascularization, was published in the New England Journal and Medicine.
January 16, 2009 - St. Jude Medical Inc. said its ViewMate II Ultrasound System with the ViewFlex PLUS Intracardiac ...
January 16, 2009 – The FDA granted Fluke Biomedical U.S. Food and Drug 510(k) clearance for the Impulse 7010 ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
January 16, 2009 – As EP procedure volume increases worldwide, clinicians are requesting intuitive, advanced tools to ...
January 16, 2009 -St. Jude Medical Inc. this week said a study was published on the St. Jude Medical Biocor Stented ...
January 15, 2009 - Implantable cardioverter defibrillators (ICDs) may reduce the risk of death by 30 percent in older ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
January 15, 2009 - The six-month follow-up examination of a 64-year-old man enrolled in SECRITT I, a pilot study ...
Is an evolution of sorts happening within advanced visualization?
January 14, 2009 - University of Ottawa Heart Institute (UOHI) researchers have successfully grown blood vessels in ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 14, 2009 - Society of Nuclear (SNM) will devote its annual Molecular Imaging Summit to introducing the new SNM ...
January 14, 2009 - According to Millennium Research Group's (MRG's) U.S. Markets for Electrophysiology (EP) Mapping and ...
January 13, 2009 - Michigan CardioVascular Institute (MCVI), a twenty-two location cardiovascular group practice based ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 13, 2009 -W.L. Gore and Associates today said it received CE Mark of its GORE VIABAHN Endoprosthesis with ...
January 13, 2009 - Cardima Inc. plans to showcase its atrial fibrillation treatment products and technologies at the ...
January 13, 2009 - Stereotaxis Inc. said the first crossing of a chronic total occlusion (CTO) using the RF PowerAssert ...
January 15, 2009
